@acrigen.com
Acrigen Biosciences is dedicated to making gene editing safe.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Acrigen Biosciences is at the forefront of Precision Gene Editing, with a mission to revolutionize medicine and bring hope to millions of patients suffering from genetic diseases. Utilizing the power of CRISPR, Acrigen is developing cutting-edge gene editing systems for use in human therapeutics. Their proprietary technology incorporates αCas and μCas CRISPR gene editors, along with engineered anti-CRISPR proteins (ErAcrs), to create a state-of-the-art editing toolbox.
This combination ensures best-in-class efficiency and precision, ultimately improving the efficacy and safety of gene editing therapies. One of Acrigen's key advancements is the discovery and engineering of αCas and μCas nucleases, specialized for human gene editing. These novel editing systems are optimized for both in vivo and ex vivo applications, expanding the scope of human genome editing.
To further enhance precision, Acrigen has developed ErAcr proteins, which selectively inhibit off-target gene editing by the CRISPR-Cas nuclease. This Cas:ErAcr pair forms the core of their precision gene editing system. If you're interested in collaborating with Acrigen, they offer licensing of their CRISPR-Cas Nuclease Library and Precision Enhancing ErAcr Proteins.
Reach out to them now to join the revolution in gene editing
Company Type
Privately Held
Company Size
2-10
Year Founded
2019
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online